tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CTXR Stock Latest News

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
Press ReleasesCitius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
21h ago
CTXR
Citius Pharmaceuticals to sell 21.4M shares at 70c in registered direct offering
PremiumThe Fly
Citius Pharmaceuticals to sell 21.4M shares at 70c in registered direct offering
19d ago
CTXR
Citius Pharmaceuticals’ lymphir Phase 1 trial adds City of Hope site
PremiumThe Fly
Citius Pharmaceuticals’ lymphir Phase 1 trial adds City of Hope site
1M ago
CTXR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ACOR
AFMD
Citius Pharmaceuticals: FDA accepts BLA resubmission of LYMPHIR
PremiumThe Fly
Citius Pharmaceuticals: FDA accepts BLA resubmission of LYMPHIR
2M ago
CTXR
Citius Pharmaceuticals files $250M mixed securities shelf
PremiumThe FlyCitius Pharmaceuticals files $250M mixed securities shelf
3M ago
CTXR
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update
3M ago
CTXR
Citius Pharmaceuticals Resubmits LYMPHIR™ License Application
PremiumCompany Announcements
Citius Pharmaceuticals Resubmits LYMPHIR™ License Application
3M ago
8K
CTXR
Citius announces resubmission of BLA to FDA forLYMPHIR
PremiumThe Fly
Citius announces resubmission of BLA to FDA forLYMPHIR
3M ago
CTXR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
NGM
NVS
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
4M ago
CTXR
Citius Pharmaceuticals completes enrollment in Phase 3 trial of Mino-Lok
PremiumThe Fly
Citius Pharmaceuticals completes enrollment in Phase 3 trial of Mino-Lok
4M ago
CTXR
Citius Pharma (CTXR) Q4 Earnings Cheat Sheet
PremiumPre-EarningsCitius Pharma (CTXR) Q4 Earnings Cheat Sheet
5M ago
CTXR
Citius Pharmaceuticals’ Lymphir shows anti-tumor activity in published study
PremiumThe Fly
Citius Pharmaceuticals’ Lymphir shows anti-tumor activity in published study
7M ago
CTXR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
CTXR
EVFM
Citius executes definitive agreement to merge subsidiary with TenX Keane
PremiumThe Fly
Citius executes definitive agreement to merge subsidiary with TenX Keane
7M ago
CTXR
TENK
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
PremiumPress Releases
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
7M ago
CTXR
Philadelphia Securities Association holds a meeting with Citius Pharmaceuticals
PremiumThe Fly
Philadelphia Securities Association holds a meeting with Citius Pharmaceuticals
8M ago
CTXR
Citius receives regulatory guidance from U.S. FDA on BLA for LYMPHIR
PremiumThe Fly
Citius receives regulatory guidance from U.S. FDA on BLA for LYMPHIR
8M ago
CTXR
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress ReleasesCitius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2023 Financial Results and Provides Business Update
9M ago
CTXR
Citius Pharmaceuticals reports Q3 EPS (6c) vs. (6c) last year
PremiumThe Fly
Citius Pharmaceuticals reports Q3 EPS (6c) vs. (6c) last year
9M ago
CTXR
Citius Pharmaceuticals reaches milestone in clinical trial of Mino-Lok solution
PremiumThe Fly
Citius Pharmaceuticals reaches milestone in clinical trial of Mino-Lok solution
9M ago
CTXR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >